Paul Glavine, Chief Growth Officer, on September 08, 2026, executed a purchase for 100,000 shares in Cybin (CYBN) for $1,247,190. Following the Form 4 filing with the SEC, Glavine has control over a total of 4,502,193 common shares of the company, with 4,271,252 shares held directly and 230,941 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1833141/000091228226001263/xslF345X05/form4.xml
Lorence H. Kim, Director, on September 08, 2026, sold 17,090 shares in Revolution Medicines (RVMD) for $3,585,837. Following the Form 4 filing with the SEC, Kim has control over a total of 1,191 common shares of the company, with 1,191 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1628171/000119312526388156/xslF345X05/ownership.xml
Kevin P Clark, Director, on September 08, 2026, sold 122,722 shares in Versigent (VGNT) for $5,718,566. Following the Form 4 filing with the SEC, Clark has control over a total of 124,849 ordinary shares of the company, with 124,849 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2078008/000119312526388150/xslF345X05/ownership.xml
Mary Beth DeNooyer, Chief Human Resources Officer, on September 08, 2026, sold 24,000 shares in Keurig Dr Pepper (KDP) for $778,200. Following the Form 4 filing with the SEC, DeNooyer has control over a total of 72,171 common shares of the company, with 72,171 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1418135/000158748426000004/xslF345X05/wk-form4_1789076957.xml